Management Team

Keith Rubin, M.D.
Founder and Chief Executive Officer
Ken Solovay
Chief Operating Officer
Luis Rios-Nogales, M.D., Ph.D., M.B.A.
Executive VP and Chief Development Officer
Stephanie Noviello, M.D., M.P.H.
Chief Medical Officer


André Morais Campos
Vice President of Global Clinical Operations
Stanley Kim, Ph.D., Esq.
Senior Vice President, Intellectual Property and Contracts
Marcel Thalen, Ph.D.
Executive Director, Drug Product Development
Peter Goldstein
Executive Director, Vaccine Platform Development


Theressa Creighton
Senior Clinical Project Manager
Steve Glazer, M.D.
Director, New Research Programs
Walter Greenblatt
Corporate Development
Jim Ramadei
Controller


Matthew Bross
Administrative Manager

Copyright 2013-2022 ILiAD Biotechnologies
Financial Conflict of Interest (FCOI) Policy